VEGFA and macular retinal edema: Intravitreal injection of bevacizumab (a monoclonal antibody targeting vascular endothelial growth factor (VEGF)) or ranibizumab (an Fab fragment that binds and neutralizes all isoforms of VEGF-A) has been reported to improve macular edema in patients with BRVO [1,2].